Previous Close | 3.5000 |
Open | 2.9000 |
Bid | 1.1500 |
Ask | 3.5000 |
Strike | 17.50 |
Expire Date | 2024-07-19 |
Day's Range | 2.9000 - 3.5000 |
Contract Range | N/A |
Volume | |
Open Interest | 90 |
FT. MYERS, Fla., May 28, 2024--NeoGenomics will showcase its versatile lung solution and its COMPASS® Hematopathology Services portfolio at ASCO 2024 in Chicago (booth #31093).
NeoGenomics, Inc. (NASDAQ:NEO) Q1 2024 Earnings Call Transcript April 30, 2024 NeoGenomics, Inc. beats earnings expectations. Reported EPS is $-0.02, expectations were $-0.03. NEO isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Welcome to the NeoGenomics First Quarter 2024 Financial […]
NeoGenomics ( NASDAQ:NEO ) First Quarter 2024 Results Key Financial Results Revenue: US$156.2m (up 14% from 1Q 2023...